Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Hashdex Nasdaq Cme Crypto Index Etf's Competitiveness

Name: Hashdex Nasdaq Cme Crypto Index Etf Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Hashdex Nasdaq Cme Crypto Index Etf (NCIQ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/NCIQ/competitors                    

                        https://api.csimarket.com/api/v1/companies/NCIQ/relationships                    

                        https://api.csimarket.com/api/v1/companies/NCIQ/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Hashdex Nasdaq Cme Crypto Index Etf's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Hashdex Nasdaq Cme Crypto Index Etf	-	-	-	Yes
High-Confidence Competitors (1)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

NCIQ Stock Performance relative to its Competitors

NCIQ Competitors (weighted) Percent change over the selected range

NCIQ Stock Performance relative to High-Confidence Competitors

NCIQ High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

Hashdex Nasdaq Cme Crypto Index Etf's Comment on Competition and Industry Peers

The XRP Ledger operates in the crypto asset space alongside competitors such as Bitcoin and Ethereum. It offers faster transaction confirmation times and supports a diverse range of applications while maintaining less complexity compared to traditional smart contract platforms like Ethereum. Ripple operates one node among over 150 validators on the XRP Ledger, with more than 35 validators included on the default Unique Node List (UNL). Recent enhancements in programmability and legal developments have influenced the public perception of XRP. The value of XRP is influenced by factors including global cryptocurrency market demand, adoption expectations, merchant acceptance, and peer-to-peer transaction volume.

Competitor data is not yet available for Hashdex Nasdaq Cme Crypto Index Etf.

Hashdex Nasdaq Cme Crypto Index Etf's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
Bitcoin	Named by the company	85%	2022 to 2026	3
Ethereum	Named by the company	85%	2022 to 2026	3
Ripple	Named by the company	85%	2022 to 2026	3

Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Hashdex Nasdaq Cme Crypto Index Etf's named competitors require a Commercial License.

Unlock Commercial Access

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.